Vaxart, Inc.
VXRT
$0.68
$0.033.91%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 43.95% | 82.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 43.95% | 82.26% | |||
| Cost of Revenue | -40.55% | 52.70% | |||
| Gross Profit | 1,772.01% | 64.68% | |||
| SG&A Expenses | -14.29% | -6.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.15% | 47.65% | |||
| Operating Income | 809.55% | 46.51% | |||
| Income Before Tax | 781.79% | 45.72% | |||
| Income Tax Expenses | 1,923.53% | -15.00% | |||
| Earnings from Continuing Operations | 776.15% | 45.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 776.15% | 45.68% | |||
| EBIT | 809.55% | 46.51% | |||
| EBITDA | 1,102.93% | 53.80% | |||
| EPS Basic | 755.62% | 45.73% | |||
| Normalized Basic EPS | 761.26% | 45.85% | |||
| EPS Diluted | 752.25% | 45.73% | |||
| Normalized Diluted EPS | 760.36% | 45.85% | |||
| Average Basic Shares Outstanding | 3.03% | 0.24% | |||
| Average Diluted Shares Outstanding | 3.16% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||